Grading the severity of airways obstruction: New wine in new bottles

European Respiratory Journal

Volumn 43, Issue 2, 2014, Pages 505-512

  Quanjer, Philip H ^a   Pretto, Jeffrey J ^b,c   Brazzale, Danny J ^d,e   Boros, Piotr W ^f  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b JOHN HUNTER HOSPITAL   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d AUSTIN HOSPITAL   (Australia)

^e Institute for Breathing and Sleep   (Australia)

^f NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIRWAY OBSTRUCTION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY MEDICINE; SEVERITY OF ILLNESS INDEX; SPIROMETRY; YOUNG ADULT;

EID: 84893470924     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00086313     Document Type: Article

References (33)

1. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202-1218.
2. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 5-40.
3. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
4. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. GOLD, 2013. Available from: www.goldcopd.org/guidelines-global-strategy-fordiagnosis- management.html
5. Quanjer PH, Enright PL, Miller MR, et al. The need to change the method for defining mild airway obstruction. Eur Respir J 2011; 37: 720-722.
6. Stanojevic S, Wade A, Stocks J, et al. Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med 2008; 177: 253-260.
7. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40: 1324-1343.
8. Peto R, Speizer FE, Cochrane AL, et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis 1983; 128: 491-500.
9. Falaschetti E, Laiho J Primatesta P, et al. Prediction equations for normal and low lung function from the Health Survey for England. Eur Respir J 2004; 23: 456-463.
10. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Med 1999; 159: 179-187.
11. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
12. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152: 1107-1136.
13. Pedone C, Scarlata S, Sorino C, et al. Does mild COPD affect prognosis in the elderly?BMC Pulm Med 2010; 10: 35.
14. Vaz Fragoso CA, Concato J, McAvay G, et al. Chronic obstructive pulmonary disease in older persons: a comparison of two spirometric definitions. Respir Med 2010; 104: 1189-1196.
15. Ekberg-Aronsson M, Pehrsson K, Nilsson J-Å, et al. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005; 6: 98.
16. Bridevaux PO, Gerbase MW, Probst-Hensch NM, et al. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax 2008; 63: 768-774.
17. Akkermans RP, Berrevoets MA, Smeele IJ, et al. Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects. BMC Pulm Med 2012; 12: 12.
18. Akkermans RP, Biermans M, Robberts B, et al. COPD prognosis in relation to diagnostic criteria for airflow obstruction in smokers. Eur Respir J 2014; 43: 54-63.
19. Vaz Fragoso CA, Gill TM, McAvay G, et al. Use of lambda-mu-sigma-derived Z score for evaluating respiratory impairment in middle-aged persons. Respir Care 2011; 56: 1771-1777.
20. Vaz Fragoso CA, Concato J, McAvay G, et al. The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181: 446-451.
21. Vaz Fragoso CA, Concato J, McAvay G, et al. Respiratory impairment and COPD hospitalisation in older persons: a competing risk analysis. Eur Respir J 2012; 40: 37-44.
22. Leivseth L, Brumpton BM, Nilsen TI, et al. GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway. Thorax 2013; 68: 914-921.
23. Mohamed Hoesein FAA, Zanen P, Lammers J-WJ. Lower limit of normal or FEV1/FVC ,0.70 in diagnosing COPD: an evidence-based review. Respir Med 2011; 105: 907-915.
24. Mannino DM, Buist AS, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 2007; 62: 237-241.
25. Mannino DM, Buist AS, Vollmer WM. Authors' reply. Thorax 2007; 62: 1108-1109.
26. Casanova C, Cote C, de Torres JP, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 591-597.
27. Cummings SR, Bates D, Black DM. Clinical use of bone densitometry: scientific review. JAMA 2002; 288: 1889-1897.
28. World Health Organization. World Health Organization Child Growth Standards. Geneva, WHO Press, 2006. Available from: www.who.int/childgrowth/ standards/Technical-report.pdf
29. Miller MR, Pedersen OF. New concepts for expressing forced expiratory volume in 1 s arising from survival analysis. Eur Respir J 2010; 35: 873-882.
30. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33: 1165-1185.
31. Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med 2012; 186: 975-981.
32. Johannessen A, Nilsen RM, Storebø M, et al. Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization. Am J Respir Crit Care Med 2013; 188: 51-59.
33. Fingleton J, Weatherall M, Beasley R. Towards individualised treatment in COPD. Thorax 2011; 66: 363-364.